Vulnerability to Hypertension Is a Major Determinant of Racial Disparities in Alzheimer's Disease Risk
- PMID: 35581146
- PMCID: PMC9340628
- DOI: 10.1093/ajh/hpac063
Vulnerability to Hypertension Is a Major Determinant of Racial Disparities in Alzheimer's Disease Risk
Abstract
Background: Higher incidence levels of Alzheimer's disease (AD) in Black Americans are well documented. However, quantitative explanations of this disparity in terms of risk-factor diseases acting through well-defined pathways are lacking.
Methods: We applied a Blinder-Oaxaca-based algorithm modified for censored data to a 5% random sample of Medicare beneficiaries age 65+ to explain Black/White disparities in AD risk in terms of differences in exposure and vulnerability to morbidity profiles based on 10 major AD-risk-related diseases.
Results: The primary contribution to racial disparities in AD risk comes from morbidity profiles that included hypertension with about 1/5th of their contribution due to differences in prevalence (exposure effect) and 4/5ths to differences in the effects of the morbidity profile on AD risk (vulnerability effect). In total, disease-related effects explained a higher proportion of AD incidence in Black Americans than in their White counterparts.
Conclusions: Disease-related causes may represent some of the most straightforward targets for targeted interventions aimed at the reduction of racial disparities in health among US older adults. Hypertension is a manageable and potentially preventable condition responsible for the majority of the Black/White differences in AD risk, making mitigation of the role of this disease in engendering higher AD incidence in Black Americans a prominent concern.
Keywords: Alzheimer’s disease; Medicare; blood pressure; hypertension; older adults; racial disparity.
© The Author(s) 2022. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                Comment in
- 
  
  Hypertension and Racial Differences in Dementia Reveal a Strategy for Risk Reduction in All Races.Am J Hypertens. 2022 Aug 1;35(8):691-693. doi: 10.1093/ajh/hpac073. Am J Hypertens. 2022. PMID: 35671347 Free PMC article. No abstract available.
References
- 
    - 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 2021; 17:327–406. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
 
        